Jefferies Maintains Hold on Hims & Hers Health, Lowers Price Target to $24
Benzinga Newsdesk 52 minutes ago
Analyst RatingsNewsPrice Target
Jefferies analyst Glen Santangelo maintains Hims & Hers Health (NYSE:HIMS) with a Hold and lowers the price target from $31 to $24.
Jefferies analyst Glen Santangelo maintains Hims & Hers Health (NYSE:HIMS) with a Hold and lowers the price target from $31 to $24.